Related Experiment Video
Updated: May 3, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
38.4K
Docetaxel-induced photolichenoid eruption.
Biju Vasudevan1, M P S Sawhney, Nitu Sharma
1Department of Dermatology, Base Hospital, Delhi Cantt, New Delhi, India.
Indian Journal of Pharmacology
|June 5, 2010
Summary
A rare skin reaction, photolichenoid eruption, was observed in a patient treated with the chemotherapy drug docetaxel. This dermatological side effect, characterized by blackish lesions, has not been previously documented in medical literature.
Area of Science:
- Dermatology
- Oncology
- Pharmacology
Background:
- Chemotherapy agents, such as docetaxel, are associated with various adverse effects.
- Skin reactions are common side effects of anti-cancer treatments.
- Previous literature has not reported photolichenoid eruptions linked to docetaxel.
Purpose of the Study:
- To report a novel case of photolichenoid eruption.
- To describe the clinical presentation and histopathology of this adverse drug reaction.
- To highlight a previously undocumented dermatological side effect of docetaxel.
Main Methods:
- Case presentation of a 58-year-old male patient.
- Clinical observation of episodic blackish discoloration on forearms and face.
- Histopathological examination of skin lesions.
- Review of patient's medication history, specifically anti-cancer drugs.
Main Results:
- The patient developed episodic, blackish skin lesions on sun-exposed areas (forearms and face).
- Lesions appeared after administration of docetaxel and lasted for two weeks per episode.
- Histopathology confirmed a lichenoid eruption.
- The reaction was determined to be a photolichenoid eruption, a novel finding in relation to docetaxel.
Conclusions:
- Photolichenoid eruption is a potential, previously unreported dermatological adverse effect of docetaxel.
- Clinicians should consider this reaction in patients on docetaxel presenting with similar skin lesions, especially after sun exposure.
- Further research is warranted to understand the mechanism and incidence of this docetaxel-induced skin reaction.
Related Concept Videos
01:11Papillary Dermis
5.8K
Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen...
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen...
5.8K
01:27Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
01:30Drug Toxicity: Allergic Reactions
209
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
209
01:01Hypersensitivity Reactions: Cytolytic Reactions
208
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
208
01:16Drug toxicity: Idiosyncratic Reactions
220
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
220
01:19Hypersensitivity Reactions: Immune-Complex Reactions
269
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
269